SCHEMBL7125552

SCHEMBL7125552

N#Cc1ccc(-c2csc(C(N)=O)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.56
KDM4E B2RXH2 4/20 0.53
VCP P55072 1/20 0.52
MAPT P10636 6/20 0.50
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
HTT P42858 4/20 0.50
ALDH1A1 P00352 3/20 0.48
MYC P01106 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
AR P10275 1/20 0.48
CDC25A P30304 1/20 0.48
CDC25B P30305 1/20 0.48
CDC25C P30307 1/20 0.48
CASP1 P29466 1/20 0.48
PARP1 P09874 1/20 0.47
PARP2 Q9UGN5 1/20 0.47
LMNA P02545 3/20 0.46
MAPK1 P28482 1/20 0.46
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6687941 0.81 LTA4H (0.61) GAAKDM4EVCPMAPTKMT2A
SCHEMBL4640043 0.80 ALOX5 (0.59) GAAKDM4EMAPTKMT2AMEN1
SCHEMBL7437902 0.80 LMNA (0.61) GAAKDM4EMAPTKMT2AMEN1
SCHEMBL2734989 0.80 RAB9A (0.54) GAAKDM4EVCPMAPTKMT2A
SCHEMBL6658975 0.80 RAB9A (0.61) GAAKDM4EMAPTKMT2AMEN1
SCHEMBL168593 0.79 ALDH1A1 (0.56) KDM4EMAPTKMT2AMEN1HTT
SCHEMBL3088513 0.79 MAP2K3 (0.50) GAAKDM4EVCPMAPTKMT2A
SCHEMBL17396331 0.78 GAA (0.56) GAAKDM4EVCPMAPTKMT2A
Hydrochloric Acid SCHEMBL30882415 0.78 MAPT (0.56) KDM4EMAPTKMT2AMEN1HTT
SCHEMBL128355 0.77 GAA (0.67) GAAKDM4EVCPMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311505-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ) PHARMACIA & UPJOHN COMPANY (US) 2003-05-21 EP claimed
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed
WO-2002016355-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC) ACETYLCHOLINE RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed
WO-2002017358-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed